Promotion of endogeneous remyelination in multiple sclerosis

Multiple Sclerosis

Volumn 3, Issue 2, 1997, Pages 71-75

  Lucchinetti, C F ^a   Noseworthy, J H ^a   Rodriguez, M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Demyelinating disease; Immunoglobulin; Remyelination; Theiler's virus

Indexed keywords

IMMUNOGLOBULIN; MYELIN;

CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DEMYELINATION; EXPERIMENTAL MODEL; HUMAN; IMMUNE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; REMYELINIZATION; ALLERGIC ENCEPHALOMYELITIS; ANIMAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; IMMUNOLOGY; MYELIN SHEATH; NERVE REGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE REGENERATION; RANDOMIZED CONTROLLED TRIALS;

EID: 0030611835     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859700300202     Document Type: Conference Paper

References (56)

1. Marburg O. (1906) Die sogenannte 'akute Multiple Sklerose'. Jahrb Psychiatrie 27: 211-312.
2. Perier O, Greqoire A. (1965) Electron microscopic features of multiple sclerosis lesions. Brain 88: 937-952.
3. Feigin I, Popoff N. (1966) Regeneration of myelin in multiple sclerosis. Neurology 16: 364-372.
4. Suzuki K, Andrews JM, Waltz JM, Terry RD. (1969) Ultrastructural studies in multiple sclerosis. Lab Invest 20: 444-454.
5. Itoyama Y, Webster HdeF, Richardson EP Jr, Trapp BD. (1983) Schwann cell remyelination of demyelinated axons in spinal multiple sclerosis lesions. Ann Neurol 14: 339-346.
6. Prineas JW, Connell F. (1979) Remyelination in multiple sclerosis. Ann Neurol 5: 22-31.
7. Prineas JW et al. (1993b) Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 33: 137-151.
8. Rodriguez M, Scheithauer BW, Forbes G, Kelley PJ. (1993) Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc 68: 627-636.
9. Rodriguez M, Scheithauer BW. (1994) Ultrastructure of multiple sclerosis. Ultrastruct Pathol 18: 3-13.
10. Lassmann H. (1983) Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Schriftner Neurol 25: 1-135.
11. Prineas JW. (1985) The neuropathology of multiple sclerosis. In: JC Koetsier (ed) Handbook of Clinical Neurology. Vol 47: Demyelinating diseases. Elsevier Science Publ. pp 337-395.
12. Bruck W et al. (1994) Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 35: 65-73.
13. Ozawa K et al. (1994) Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117: 1311-1322.
14. Blakemore WF. (1973) Demyelination in the superior cerebellar peduncle in the mouse induced by cuprizone. J Neurol Sci 20: 63-72.
15. Yajima K, Suzuki K. (1979) Demyelination and remyelination in the rat central nervous system following ethidium bromide injection. Lab Invest 41: 385-392.
16. Hall SM. (1972) The effects of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci 13: 257-277.
17. Ludwin SK. (1988) Remyelination in the central nervous system and the peripheral nervous system. Adv Neurol 47: 215-254.
18. Ludwin SK. (1980) Chronic demyelination inhibits remyelination in the central nervous system: an analysis of contributing factors. Lab Invest 43: 382-387.
19. Gilson J, Blakemore WF. (1993) Failure of remyelination in areas of demyelination produced in the spinal cord of old rats. Neuropathol Appl Neurobiol 19: 173-181.
20. Zamvil SS, Steinman LS. (1990) The T lymphocytre in experimental allergic encephalomyelitis. Ann Rev Immunol 8: 579-621.
21. Raine CS, Traugott U. (1985) Remyelination in chronic relapsing experimental allergic encephalomyelitis and multiple sclerosis. In: Adachi M, Hirano A, Aronson SM (eds). The pathology of the myelinated axon. Igaku-Shoin: New York, pp 229-275.
22. Traugott U, Stone SH, Raine CS. (1982) Chronic relapsing experimental autoimmune encephalomyelitis: treatment with combinations of myelin components promotes clinical and structural improvement. J Neurol Sci 56: 65-73.
23. Raine CS, Traugott U. (1983) Chronic relapsing experimental autoimmune encephalomyelitis: ultrastructure of the central nervous system of animals treated with combination of myelin components. Lab Invest 48: 275-284.
24. Lang W, Rodriguez M, Lennon VA, Lampert PW. (1984) Demyelination and remyelination in murine viral encephalomyelitis. Ann NY Acad Sci 436: 98-102.
25. Rodriguez M, Oleszak E, Leibowitz J. (1987) Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. CRC Crit Rev Immunol 7: 325-365.
26. Rodriguez M, Lennon VA, Benveniste EN, Merrill JE. (1987) Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J Neuropathol Exp Neurol 46: 84-95.
27. Rodriguez M, Lennon VA. (1990) Immunoglobulins promote remyelination in the central nervous system. Ann Neurol 27: 12-17.
28. Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M. (1994) Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 14: 6230-6238.
29. Miller DJ, Rodriguez M. (1995) A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes. J Immunol 154: 2460-2469.
30. Asakura K, Pogulis R, Pease LR, Rodriguez M. (1996b) A monoclonal autoantibody which promotes central nervous system remyelination is highly polyreactive to multiple known and novel antigens. J Neuroimmunol 65: 11-19.
31. Asahura K et al. (1996a) Monoclonal autoantibody SCH94.03 which promotes central nervous system remyelination recognizes an antigen on the surface of oligodendrocytes. J Neurosci Res 43: 273-281.
32. Raine CS, Scheinberg LC, Waltz JM. (1981) Multiple sclerosis: oligodendrocyte survival and proliferation in an active established lesion. Lab Invest 45: 534-546.
33. Lehrer GM et al. (1979) Stimulation of myelin lipid synthesis in vitro by white matter antiserum in the absence of complement. Brain Res 172: 557-560.
34. Bansal R, Gard AL, Pfeiffer SE. (1988) Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid. J Neurosci Res 21: 260-267.
35. Benjamins JA, Dyer CA. (1990) Glycolipids and transmembrane signaling in oligodenroglia. Ann NY Acad Sci 605: 90-100.
36. Rodriguez M, Lindsley MD. (1992) Immunosuppression promotes CNS remyelination in chronic virus-induced demyelianting disease. Neurology 42: 348-367.
37. Miller DJ et al. (1996a) A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination. Int Immunol 8: 131-141.
38. Miller DJ et al. (1995) Spontaneous CNS remyelination in beta-2-microglobulin-deficient mice following virus-induced demyelination. J Neurosci 15: 8345-8352.
39. vanEngelen BG et al. (1994) Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis. J Neurol Neurosurg Psych 57: 65-68.
40. Imbach P, Barundun S, d'Apuzzo V. (1981) High-dose intraveneous immunoglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1: 1228-1231.
41. Newburger JW, Takahashi M, Burns JC. (1986) The treatment of Kawasaki's syndrome with gammaglobulin. N Engl J Med 315: 341-347.
42. Kleywig RP, Van der Meche FGA, Meulstee J. (1988) Treatment of Guillan-Barre syndrome with high dose gamma globulin. Neurology 38: 1639-1641.
43. Cornblath DR, Chaudhry V, Griffin JW. (1991) Treatment of chronic inflammatory demyelinating polyneuropathy with intraveneous immunoglobulin. Ann Neurol 30: 104-106.
44. Miller HG et al. (1963) Multiple sclerosis: therapeutic trials of chloroquine, soluble aspirin, and gammaglobulin. Br Med J 1: 1436-1439.
45. Schuller E, Govaerts A. (1983) First results of immunotherapy with immunoglobulin G in multiple sclerosis patients. Eur Neurol 22: 205-212.
46. Cook SD et al. (1992) Intraveneous gamma globulin in progressive multiple sclerosis. Acta Neurol Scand 86: 171-175.
47. Yan J, Richert JR, Sirdofsky MD. (1990) High-dose intravenous immunoglobulin for multiple sclerosis. Lancet 2: 692.
48. Achiron A, Pras E, Gilad R. (1992) Open controlled therapeutic trial of intravenous immunoglobulins in relapsing-remitting multiple sclerosis. Arch Neurol 49: 1233-1236.
49. Fazekas F, Deisenhammer F, Strasser-Fuchs S et al. (1997) Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Lancet 349: 589-593.
50. Frohman LP, Cook SD, Bielroy L. (1991) Dysgammaglobulinemia in steroid-dependent optic neuritis: response to gammaglobulin treatment. J Clin Neuro Ophthalmol 11(4): 241-245.
51. vanEngelen BGM et al. (1992) Improved vision after intraveneous immunoglobulin in stable demyelinating optic neuritis. Ann Neurol 32: 835-836.
52. Noseworthy JH, O'Brien PC, vanEngelen BG, Rodriguez M. (1994) Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial. J Neurol Neurosurg Psychiat 57(Suppl): 11-14.
53. Kurtzke JF. (1973). Studies on the natural history of multiple sclerosis. Correlates of clinical change in an early bout. Acta Neurol Scand 49: 379-395.
54. Sandberg-Wolheim M et al. (1990) A longterm prospective study of optic neuritis: evaluation of risk factors. Ann Neurol 27: 386-393.
55. Riikonen R, Donner M, Erkkila H. (1988) Optic neuritis in children and its relationship to multiple sclerosis: a clinical study of 21 children. Dev Med Child Neurol 30: 349-359.
56. Beck RW et al. (1992) A randomized controlled trial of corticosteroids in the treatment of optic neuritis. N Engl J Med 326: 581-588.